Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
UFPT
BUYUFP Technologies, Inc. · Healthcare · United States · $1.8B · Avg Vol: $52M/d
COMPANY DESCRIPTION
UFP Technologies, Inc. designs and custom manufactures highly engineered thermoplastic and composite foam components and products, with a primary focus on the demanding healthcare market. The company distinguishes itself through its expertise in advanced materials and custom-engineered solutions, providing critical components and sterile barrier packaging for medical device OEMs. UFP Technologies operates as a niche, high-value-added partner in highly regulated industries.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 353.8M | 400.1M | 504.4M | 602.8M | 19.4% | 608.9M | 640.0M | 679.0M | 6.1% |
| EPS | 5.52 | 5.89 | 7.69 | 8.87 | 17.1% | 8.92 | 9.44 | 10.62 | 9.4% |
| Shares | 7.6M | 7.6M | 7.7M | 7.7M | +1.7% | 7.7M | — | — | — |
| Debt | 68.4M | 46.0M | 206.0M | 154.5M | 31.2% | 156.1M | — | — | — |
| Equity | 237.5M | 286.1M | 342.8M | 423.9M | 21.3% | — | — | — | — |
| Op CF | 17.7M | 41.3M | 66.6M | 91.9M | 73.0% | 81.3M | — | — | — |
| Inv CF | 1.3M | -10.5M | -210.2M | -27.6M | — | — | — | — | — |
| Fin CF | -25.9M | -30.0M | 152.4M | -58.2M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of UFPT are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| UFPT | UFP Technologies, Inc.(you) | $1.8B | 78 | BUY |
| IART | Integra LifeSciences Holdings Corporation | $1.5B | 79 | BUY |
| ENOV | Enovis Corporation | $1.6B | 82 | STRONG BUY |
| AHCO | AdaptHealth Corp. | $1.5B | 80 | STRONG BUY |
| IRMD | IRADIMED CORPORATION | $1.2B | 79 | BUY |
| AVNS | Avanos Medical, Inc. | $1.2B | 72 | BUY |
| CNMD | CONMED Corporation | $1.3B | 87 | STRONG BUY |
| ITGR | Integer Holdings Corporation | $3.3B | 73 | BUY |
| AXGN | Axogen, Inc. | $2.1B | 63 | HOLD |
| HAE | Haemonetics Corporation | $3.6B | 89 | STRONG BUY |
Peer medians: ROE -25.6% · P/E 27.7x · Gross margin 50.6%